Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
RSV Prevention — Breakthroughs and Challenges
by
Halasa, Natasha B.
in
Antiviral Agents - therapeutic use
/ Childhood Diseases
/ Disease prevention
/ Effectiveness
/ Gestational age
/ Global Health
/ Hospitalization
/ Humans
/ Immunization
/ Infections
/ Infectious Disease
/ Infectious Disease General
/ Low income groups
/ Monoclonal antibodies
/ Palivizumab - therapeutic use
/ Pediatrics
/ Respiratory syncytial virus
/ Respiratory Syncytial Virus Infections - prevention & control
/ Respiratory tract infection
/ Vaccines
/ Viral Infections
2023
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
RSV Prevention — Breakthroughs and Challenges
by
Halasa, Natasha B.
in
Antiviral Agents - therapeutic use
/ Childhood Diseases
/ Disease prevention
/ Effectiveness
/ Gestational age
/ Global Health
/ Hospitalization
/ Humans
/ Immunization
/ Infections
/ Infectious Disease
/ Infectious Disease General
/ Low income groups
/ Monoclonal antibodies
/ Palivizumab - therapeutic use
/ Pediatrics
/ Respiratory syncytial virus
/ Respiratory Syncytial Virus Infections - prevention & control
/ Respiratory tract infection
/ Vaccines
/ Viral Infections
2023
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
RSV Prevention — Breakthroughs and Challenges
by
Halasa, Natasha B.
in
Antiviral Agents - therapeutic use
/ Childhood Diseases
/ Disease prevention
/ Effectiveness
/ Gestational age
/ Global Health
/ Hospitalization
/ Humans
/ Immunization
/ Infections
/ Infectious Disease
/ Infectious Disease General
/ Low income groups
/ Monoclonal antibodies
/ Palivizumab - therapeutic use
/ Pediatrics
/ Respiratory syncytial virus
/ Respiratory Syncytial Virus Infections - prevention & control
/ Respiratory tract infection
/ Vaccines
/ Viral Infections
2023
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
RSV Prevention — Breakthroughs and Challenges
2023
Request Book From Autostore
and Choose the Collection Method
Overview
Since the discovery of respiratory syncytial virus (RSV) in 1956, the pathogen has become well recognized as a leading cause of acute respiratory illness worldwide. By 2 years of age, most children have been infected with RSV, with illnesses ranging from mild upper respiratory tract infection to severe and sometimes fatal lower respiratory tract infection. In 2019, there were an estimated 33 million cases of acute lower respiratory tract infection due to RSV, resulting in 3.6 million hospitalizations and 26,300 in-hospital deaths among children younger than 5 years of age worldwide.
1
In addition, 101,400 deaths were attributable to RSV.
1
However, . . .
Publisher
Massachusetts Medical Society
MBRLCatalogueRelatedBooks
Related Items
Related Items
We currently cannot retrieve any items related to this title. Kindly check back at a later time.
This website uses cookies to ensure you get the best experience on our website.